| Lung Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 331show all (up to 200) |
|---|
| → investigated in trials for | Carboplatinsmall molecule 670 trials (239 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 670 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 500 trials (167 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 500 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 447 trials (140 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 447 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 438 trials (202 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 438 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 346 trials (104 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 346 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 320 trials (76 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 320 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 211 trials (73 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 211 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 199 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 199 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 197 trials (91 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 197 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 194 trials (34 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 194 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 189 trials (35 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 167 trials (67 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 167 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 166 trials (58 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 166 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 162 trials (90 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 162 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 102 trials (45 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 102 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 99 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 99 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 89 trials (36 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 74 trials (42 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 73 trials (24 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 69 trials (18 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 69 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 66 trials (23 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 66 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 61 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 52 trials (38 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 51 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 50 trials (14 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 45 trials (17 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 44 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Firmonertinibsmall molecule 42 trials (29 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 42 trials (17 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 41 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 36 trials (17 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 35 trials (19 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 34 trials (13 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 34 trials (17 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 32 trials (27 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 31 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 30 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 30 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 29 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aumolertinibsmall molecule 26 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 26 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 25 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amivantamabmonoclonal antibody 24 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 24 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall_molecule 24 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 24 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 23 trials (21 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 23 trials (12 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lazertinibsmall molecule 23 trials (12 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 23 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 22 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 21 trials (15 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 20 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 19 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 19 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 16 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 16 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ensartinibsmall molecule 15 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 14 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunvozertinibsmall molecule 12 trials (12 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amrubicinsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rovalpituzumab Tesirineadc 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Necitumumabmonoclonal antibody 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tepotinibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Divarasibsmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Poziotinibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pyrotinibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rociletinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sevabertinibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taxol 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Befotertinibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacomitinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Naquotinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onartuzumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taletrectinibsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Repotrectinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Motesanibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinib Mesylatesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | TAK-788small molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tyrosine Kinase Inhibitor 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zongertinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Conatumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pictilisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pilaralisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum Doublet 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rilotumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Carcinoma | 2 | Observed | clinicaltrials | graph → |